search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Nurses' led home support for type 2 diabetes patients with an acute coronary syndrome.


- candidate number10370
- NTR NumberNTR3076
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR20-sep-2011
- Secondary IDs2009.70 Diabetes Fonds
- Public TitleNurses' led home support for type 2 diabetes patients with an acute coronary syndrome.
- Scientific TitleLiving with diabetes: Nurses' led tailored home support for type 2 diabetes patients with a recent acute cardiac syndrome. A pragmatic trial in primary care.
- ACRONYMLiving with diabetes
- hypothesisThe overall objective of this study is to develop and evaluate the effectiveness of a tailored supportive intervention by a diabetes nurse to help people with type 2 diabetes cope with the occurrence of an acute cardiac syndrome (ACS) that might influence their QOL considerably.
Primary Objective: To evaluate the effectiveness of home visits by a diabetes nurse on QOL in DM2 patients who recently suffered from an ACS.
Secondary objectives: To assess the effectiveness of the intervention on depression, self-management behaviour, self-efficacy, and illness perceptions.
- Healt Condition(s) or Problem(s) studiedPrimary care, Diabetes Mellitus Type 2 (DM type II), Acute coronary syndrome (ACS), Selfmanagement
- Inclusion criteria1. DM2 patients;
2. At time of inclusion in the hospital or very recently dismissed from the hospital after their first ACS;
3. Sufficient knowledge of the Dutch language.
- Exclusion criteria1. Not speaking or understanding the Dutch language;
2. Not able to fill in questionnaires.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingSingle
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 15-okt-2011
- planned closingdate31-mrt-2013
- Target number of participants200
- InterventionsA diabetes nurse, trained for this project, visits the patients three times at home:
1. Within three weeks after discharge from the hospital;
2. Two weeks after the first home visit;
3. Two months after the second home visit.
During the home visits, the following subjects will be discussed:
A. Illness perception, guided by the completed IPQ-R (Revised Illness perception questionnaire). Discuss the extent to which patients think that DM2 is an extra burden in recovering from and coping with the consequences of the cardiac event;
B. The role of DM2 in the aetiology of the cardiac event;
C. Nutrition/diet;
D. What to do and not to do regarding sexuality and other physical activity;
E. Pharmacotherapy. Treatment may be already very complicated in DM2 patients. When the disease is complicated by a cardiac event, pharmacotherapy may even become more complicated;
F. Agreements on the control scheme with different health care providers. After a cardiac event, DM2 patients sometimes skip their controls at the general practice because they think the controls at the cardiologist are sufficient.

Participants who will be randomised to the control group will receive usual care. In addition, they will receive a consultation by telephone to offer them personal attention.
- Primary outcomeHealth-related QOL, both generic and diabetes-specific. This will be measured as diabetes distress and well-being.
- Secondary outcome1. Depression;
2. Self-management behaviour;
3. HbA1c% and exercise;
4. Self-efficacy;
5. Illness perception;
6. Medication adherence.
- TimepointsThe baseline measurements T(0) will be conducted within three weeks after discharge from the hospital. The final measurements will be performed four to five months after discharge from the hospital (T1)
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESMSc. M.J. Kasteleyn
- CONTACT for SCIENTIFIC QUERIESDr. K.J. Gorter
- Sponsor/Initiator University Medical Center Utrecht (UMCU), Julius Center for Health Sciences and Primary Care
- Funding
(Source(s) of Monetary or Material Support)
Dutch Diabetes Foundation
- PublicationsN/A
- Brief summaryRationale:
Type 2 diabetes (DM2) patients have an increased risk of cardiovascular complications. Both DM2 and cardiac disease are associated with a decreased quality of life (QOL) and combination of these diseases results in an even more decreased QOL. Self-management is an important part of diabetes care, and in addition has a positive impact on QOL; however for most patients it is difficult for to perform self-management tasks, because they lack self-efficacy. Therefore, self-management support in DM2 patients with an acute cardiac syndrome (ACS) is important for improving self-efficacy and QOL.

Objective:
To develop and evaluate the effectiveness of a tailored supportive intervention by a diabetes nurse to help people with DM2 to cope with the occurrence of an ACS that might influence their QOL.

Study design:
Randomised controlled trial. Patients will be randomised in an intervention group, receiving usual care and a tailored intervention, and in a control condition. The control condition receives usual care and a consultation by telephone. Study population: DM2 patients with a myocardial infarction (MI) and/or revascularisation procedure within three weeks after discharge from the hospital.

Intervention:
A diabetes nurse, trained for this study, will visit the patients in the intervention group three times at home to discuss several subjects, including illness perceptions, diet, physical activity, pharmacotherapy, the role of DM2 in the cardiac event and the frequency of controls.

Main study parameters/endpoints:
Primary: Diabetes distress and health related QOL.
Secondary: Depression, self-management behaviour, HbA1c%, exercise, self-efficacy and illness perceptions. Other: biomedical and life style measures.
- Main changes (audit trail)
- RECORD20-sep-2011 - 21-okt-2011


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl